发明授权
US07638523B2 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
有权
含二芳基胺的化合物和组合物，以及它们作为c-kit受体调节剂的用途
- 专利标题： Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
- 专利标题（中）： 含二芳基胺的化合物和组合物，以及它们作为c-kit受体调节剂的用途
-
申请号： US11933030申请日： 2007-10-31
-
公开(公告)号： US07638523B2公开(公告)日： 2009-12-29
- 发明人: Valentina Molteni , Shuli You , Juliet Nabakka , Yi Liu , Xiaolin Li , Donatella Chianelli , Jon Loren , Xiaodong Liu , Shifeng Pan , Donald S. Karanewsky , Pascal Furet , Vito Guagnano
- 申请人： Valentina Molteni , Shuli You , Juliet Nabakka , Yi Liu , Xiaolin Li , Donatella Chianelli , Jon Loren , Xiaodong Liu , Shifeng Pan , Donald S. Karanewsky , Pascal Furet , Vito Guagnano
- 申请人地址： BM Hamilton CH Basel
- 专利权人： IRM LLC,Novartis AG
- 当前专利权人： IRM LLC,Novartis AG
- 当前专利权人地址： BM Hamilton CH Basel
- 代理机构： Genomics Institute of the Novartis Research Foundation
- 代理商 Daniel E. Raymond
- 主分类号： A61K31/505
- IPC分类号： A61K31/505 ; A61K31/506 ; A61P19/02 ; A61P37/08 ; A61P9/02 ; A61P17/06 ; A61P1/04 ; A61P1/16 ; A61P25/20 ; C07D239/42 ; C07D403/10 ; C07D403/14
摘要：
Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.
公开/授权文献
信息查询
